Translate
Translate this website into the following languages:



Close Tab
Donations
UC San Diego Health
menu iconMenu
search iconSearch

Nobel Prize-Winning Neuroscientist to Speak at UCSD January 10

 

January 04, 2007  |  

Dr. Paul Greengard, head of the Laboratory of Molecular and Cellular Neuroscience at The Rockefeller University and co-recipient of the 2000 Nobel Prize in Physiology or Medicine, will speak at the University of California, San Diego (UCSD) on Wednesday, January 10th at 11:00 a.m.

His lecture, "Signal transduction pathways used by therapeutic agents and drugs of abuse," is sponsored by the UCSD Neurosciences Graduate Program and Department of Pharmacology. The free lecture is open to the public, and will be presented at Mandeville Auditorium on the UCSD campus in La Jolla.

Greengard, Eric Kandel and Arvid Carlsson were awarded the Nobel Prize for their discoveries concerning signal transduction in the nervous system.  Greengard’s work has contributed to the understanding of how dopamine and a number of other neurotransmitters – specialized chemical messengers that send signals from one cell to another – work in the central nervous system.  Signaling abnormalities by dopamine are associated with several neurological disorders, including Parkinson's disease, schizophrenia, attention deficit hyperactivity disorder, and substance abuse. 

He has also shown that many of the therapeutic and toxic effects of several classes of common antipsychotic, hallucinogenic and antidepressant drugs can be explained in terms of the distinct neurochemical actions by which they affect the transmission of nerve signals in the brain.

Funding for the lecture was provided in part by a Neuroplasticity of Aging Training Grant from the National Institutes of Health.  For more information please contact Lisa Kurtz at lmkurtz@ucsd.edu

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu 

 


Related Specialties

Neurosciences


Media Contact

Share This Article


Related News

12/7/2016
Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have now determined the 3D structure of CCR2 simultaneously bound to two inhibitors. Unde ...
12/6/2016
Patients at the newly opened Jacobs Medical Center at UC San Diego Health can be in command of their own experience by controlling room temperature, lighting, accessing their personal medical informat ...
12/1/2016
Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role ...
11/30/2016
On November 4, 2016, surgeons at UC San Diego Health performed the region’s first combined heart-liver transplant (CHLT). During the 10-hour surgery, 54-year old Frank “Sonny” Taitano received a healt ...



Follow Us

Our bimonthly newsletter delivers healthy lifestyle tips, patient stories and research discovery news. Subscribe: